FierceBiotech Feb 20, 2026 Grail stock craters as key NHS-Galleri cancer blood test trial fails to hit primary endpoint
FierceBiotech Feb 20, 2026 Candel glows brighter with $100M RTW royalty deal to fund prostate cancer drug's launch
FierceBiotech Feb 19, 2026 Sanofi backs Altesa's $75M series B to bankroll antiviral's midstage rhinovirus study
FierceBiotech Feb 19, 2026 J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy
FierceBiotech Feb 19, 2026 GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research
FierceBiotech Feb 19, 2026 NIH Director Jay Bhattacharya to take over as temporary CDC chief: media reports
FierceBiotech Feb 18, 2026 Blood from pediatricians yields potential new medicines for respiratory viruses